Leave a Comment

Please enter your name.
Please enter a comment.

Trending
Lexington
Aducanumab: the beginning of the end of Alzheimer’s disease?
Aducanumab: the beginning of the end of Alzheimer’s disease?
Credit card in hand
Step aside, biomarkers. Look to the bank account for…
Step aside, biomarkers. Look to the bank account for early signs of dementia
Vertex Pharmaceuticals - sunset
‘A game-changer’: How Vertex delivered on cystic fibrosis
‘A game-changer’: How Vertex delivered on cystic fibrosis
Recommended
Lexington
Aducanumab: the beginning of the end of Alzheimer’s disease?
Aducanumab: the beginning of the end of Alzheimer’s disease?
SNAP
Cutting 700,000 Americans from SNAP will increase health costs
Cutting 700,000 Americans from SNAP will increase health costs
Cell-cial network
Creating a Facebook for cell communication can help treat…
Creating a Facebook for cell communication can help treat disease

Recommended Stories

Lexington
First Opinion

Aducanumab: the beginning of the end of Alzheimer’s disease?

By Jason Karlawish

SNAP
First Opinion

Cutting 700,000 Americans from SNAP will increase health costs

By Stephanie Ettinger de Cuba, Diana B. Cutts, and Allison Bovell-Ammon

Cell-cial network
First Opinion

Creating a Facebook for cell communication can help treat disease

By Virginia Savova

Flood gate
First Opinion

Biogen’s good news on aducanumab could ‘open the floodgates’ for Alzheimer’s drugs

By Dennis J. Selkoe

Credit card in hand
First Opinion

Step aside, biomarkers. Look to the bank account for early signs of dementia

By Eric Chess

Your daily dose of news in health and medicine

Privacy Policy